Fundamentals Hub
GLUC Glucose Health, Inc.
GLUC financial statements, revenue, balance sheet, cash flow, and SEC filings
Showing 3 of 7 annual and 0 of 26 quarterly periods.
Full history available with a free account or via API.
▼ Company Profile
Filer Category
Smaller reporting company
Entity Type
Operating
Public Float
$78.49K (Jun 2016)
Industry (SIC)
2833 Medicinal Chemicals & Botanical Products
Incorporated
DE
Fiscal Year End
December (1231)
Phone
479-802-3827
EIN
901117742
Headquarters
BENTONVILLE, AR, 72712
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names:
Bio-Solutions Corp. (2007–2014)
▼ Key Metrics (TTM)
As of Sep 30, 2017Financials
Revenue
-
Net Income
$-93.97K
Total Assets
$26.35K
Total Equity
$-426.23K
Total Debt
-
Free Cash Flow
-
Ratios
Return on Equity
22%
Return on Assets
-356.6%
Current Ratio
0.06x
Sources and calculation details
Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.
Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.
Annual (FY)
Quarterly 🔒
Chart 🔒
| Metric | FY2016 📄 | FY2015 📄 | FY2014 📄 |
|---|---|---|---|
| Income Statement | |||
| REVENUE | |||
| Cost of Revenue | $294.06K | $3.88K | $23.47K |
| Gross Profit | $19.17K | $397 | $-20.73K |
| OPERATING EXPENSES | |||
| R&D Expense | - | $48 | $4.00K |
| SG&A Expense | $51.84K | $114.82K | $16.30K |
| Other Operating Expenses (derived) | - | $41.70K | $504.19K |
| Operating Income | $-86.65K | $-156.17K | $-545.22K |
| NON-OPERATING INCOME / EXPENSE | |||
| Interest Expense | $323.80K | $120.03K | $109.63K |
| Other Income/Expense | $-323.80K | $-109.89K | $-124.19K |
| Pretax Income | $-410.44K | $-266.06K | $-669.41K |
| Net Income | $-410.44K | $-266.06K | $-669.41K |
| PER SHARE & SUPPLEMENTAL | |||
| Balance Sheet | |||
| ASSETS | |||
| Cash & Equivalents | $20.54K | $2.06K | $4.87K |
| Accounts Receivable | $11.72K | $3.15K | - |
| Inventory | - | $8.37K | $0 |
| Other Current Assets | $639 | $1.28K | $38.86K |
| Current Assets | $32.91K | $15.11K | $43.73K |
| Noncurrent Assets | $240 | $300 | $300 |
| Total Assets | $33.15K | $15.41K | $44.03K |
| LIABILITIES | |||
| Accounts Payable | $138.13K | $94.92K | $154.66K |
| Short-term Debt | - | - | $169.92K |
| Other Current Liabilities (derived) | - | - | $0 |
| Current Liabilities | $528.59K | $403.23K | $324.58K |
| Noncurrent Liabilities | $0 | $0 | $0 |
| Total Liabilities | $528.59K | $403.23K | $324.58K |
| EQUITY | |||
| Common Stock | $3.31K | $2.45K | $1.31K |
| Additional Paid-in Capital | $120.00K | $5.39M | $5.23M |
| Retained Earnings | $-6.25M | $-5.84M | $-5.57M |
| Accumulated OCI | $-75.28K | $-75.28K | $-75.28K |
| Total Equity | $-495.45K | $-387.82K | $-280.55K |
| Total Liabilities & Equity | $33.15K | $15.41K | $44.03K |
| SUPPLEMENTAL | |||
| Shares Outstanding | 3.31M | 2.45M | 1.31M |
| Check: A − (L + E + NCI) | - | - | - |
| Cash Flow Statement | |||
| Cash from Operations | $-39.26K | $-115.78K | $-135.35K |
| Capital Expenditures | - | - | - |
| Cash from Investing | $250 | $-250 | - |
| Cash from Financing | $57.50K | $113.21K | $139.51K |
| Free Cash Flow | - | - | - |
| Beginning Cash (CFS) | $2.06K | $4.87K | - |
| Net Change in Cash | $18.49K | $-2.82K | - |
| Effect of FX on Cash | - | - | - |
| Calculated Ending Cash | $20.54K | $2.06K | - |
| Cash per BS | $20.54K | $2.06K | $4.87K |
| Cash scope difference (CFS − BS) | - | - | - |
| Cash per CFS | $20.54K | $2.06K | $4.87K |
Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.
Create Free Account Log In🔒
Quarterly data and charts require a free account
Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.
▼ Frequently Asked Questions
Is Glucose Health, Inc. profitable?
No. Glucose Health, Inc. reported $-93.97K in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.